Skip to content
Open access · CC-BY via OpenAlex

Taurine from tumour niche drives glycolysis to promote leukaemogenesis

Sonali Sharma, Benjamin J. Rodems, Cameron D. Baker, Christina M. Kaszuba, Edgardo I. Franco, Bradley R. Smith, Takashi Ito, Kyle Swovick, Kevin A. Welle, Yi Zhang, Philip J. Rock, Francisco A. Chaves, Sina Ghaemmaghami, Laura Maria Calvi, Archan Ganguly

Nature · 2025 · ▲ 53 citations

Abstract

ABSTRACT Signals from the microenvironment are known to be critical for development, sustaining adult stem cells, and for oncogenic progression. While candidate niche-driven signals that can promote cancer progression have been identified 1–6 , concerted efforts to comprehensively map microenvironmental ligands for cancer stem cell specific surface receptors have been lacking. Here, we use temporal single cell RNA-sequencing to identify molecular cues from the bone marrow stromal niche that engage leukemia stem cells (LSC) during oncogenic progression. We integrate these data with our RNA-seq analysis of human LSCs from distinct aggressive myeloid cancer subtypes and our CRISPR based in vivo LSC dependency map 7 to develop a temporal receptor-ligand interactome essential for disease progression. These analyses identify the taurine transporter (TauT)-taurine axis as a critical dependency of myeloid malignancies. We show that taurine production is restricted to the osteolineage population during cancer initiation and expansion. Inhibiting taurine synthesis in osteolineage cells impairs LSC growth and survival. Our experiments with the TauT genetic loss of function murine model indicate that its loss significantly impairs the progression of aggressive myeloid leukemias in vivo by downregulating glycolysis. Further, TauT inhibition using a small molecule strongly impairs the growth and survival of patient derived myeloid leukemia cells. Finally, we show that TauT inhibition can synergize with the clinically approved oxidative phosphorylation inhibitor venetoclax 8, 9 to block the growth of primary human leukemia cells. Given that aggressive myeloid leukemias continue to be refractory to current therapies and have poor prognosis, our work indicates targeting the taurine transporter may be of therapeutic significance. Collectively, our data establishes a temporal landscape of stromal signals during cancer progression and identifies taurine-taurine transporter signaling as an important new regulator of myeloid malignancies.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1038/s41586-025-09018-7
Canonical
link ↗
Fetched
2026-11-05 MST

Cite this

APA
Sharma, S., Rodems, B.J., Baker, C.D., Kaszuba, C.M., Franco, E.I., Smith, B.R., Ito, T., Swovick, K., Welle, K.A., Zhang, Y., Rock, P.J., Chaves, F.A., Ghaemmaghami, S., Calvi, L.M., Ganguly, A., Burack, R., Becker, M.W., Liesveld, J.L., Brookes, P.S., &amp; Munger, J.C. (2025). Taurine from tumour niche drives glycolysis to promote leukaemogenesis. <em>Nature</em>. https://doi.org/10.1038/s41586-025-09018-7
Vancouver
Sharma S, Rodems BJ, Baker CD, Kaszuba CM, Franco EI, Smith BR, et al. Taurine from tumour niche drives glycolysis to promote leukaemogenesis. Nature. 2025. doi:10.1038/s41586-025-09018-7.
BibTeX
@article{sonali2025Taurin, title = {Taurine from tumour niche drives glycolysis to promote leukaemogenesis}, author = {Sonali Sharma and Benjamin J. Rodems and Cameron D. Baker and Christina M. Kaszuba and Edgardo I. Franco and Bradley R. Smith and Takashi Ito and Kyle Swovick and Kevin A. Welle and Yi Zhang and Philip J. Rock and Francisco A. Chaves and Sina Ghaemmaghami and Laura Maria Calvi and Archan Ganguly and Richard Burack and Michael W. Becker and Jane L. Liesveld and Paul S. Brookes and Joshua C. Munger and Craig T. Jordan and John M. Ashton and Jeevisha Bajaj}, journal = {Nature}, year = {2025}, doi = {10.1038/s41586-025-09018-7}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings